Boston
,
US
24 - 27 October 2023
16th Clinical Trials on Alzheimer's Diseas (CTAD 2023)
Presentation schedule and materials
Tuesday, 24 October 2023
09:00
EDT
LP056
POSTER
The role of neuroinflammation in Alzheimer’s disease: A systematic literature review
Michael T Heneka1; Serge Gauthier2; Sagar Anil Chandekar3; Julie Hviid Hahn-Pedersen3; Marie Bentsen3; Henrik Zetterberg4,5,6,7,8,9
09:00
EDT
LP018
POSTER
Preliminary baseline characteristics from evoke and evoke+: Two phase 3 randomized placebo-controlled trials of oral semaglutide in patients with early Alzheimer’s disease
Philip Scheltens1; Alireza Atri2,3,4; Howard H Feldman5; Oskar Hansson6,7; Filip K Knop8,9,10,11; Mary Sano12,13; Claus Dethlefsen14; Peter Johannsen14; Teresa León Colombo14; Charlotte T Hansen14; Jeffrey Cummings15
Keywords